(327 days)
ECG monitoring electrodes for short-term use (
Pregelled electrodes are of Ag/AgCl construction with a sensor element area between 10 and 20 mm in diameter, and an adhesive part between 20 and 70 mm in diameter or rectangular/square in shape. Electrodes are bulk packaged in OPP/PE laminated pouches; 60/pouch; 300/box.
The provided text is a 510(k) summary for the Niko ECG Monitoring Electrodes and a letter from the FDA regarding its clearance. It does not contain information about specific acceptance criteria or a study proving the device meets those criteria.
The document only states that the device is substantially equivalent to legally marketed predicate devices. This means that the FDA determined the device has the same intended use and technological characteristics as a predicate device, or if it has different technological characteristics, that the new device does not raise different questions of safety and effectiveness. The 510(k) process typically relies on demonstrating substantial equivalence rather than requiring a full clinical trial with defined acceptance criteria and detailed performance studies in the way a PMA (Premarket Approval) might.
Therefore, I cannot provide the requested information from the given text. The text does not describe:
- A table of acceptance criteria and reported device performance.
- Sample sizes or data provenance for test sets.
- Number or qualifications of experts for ground truth.
- Adjudication methods.
- MRMC comparative effectiveness study or effect size.
- Standalone performance.
- Type of ground truth used.
- Sample size for the training set.
- How ground truth for the training set was established.
§ 870.2360 Electrocardiograph electrode.
(a)
Identification. An electrocardiograph electrode is the electrical conductor which is applied to the surface of the body to transmit the electrical signal at the body surface to a processor that produces an electrocardiogram or vectorcardiogram.(b)
Classification. Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 870.9. The special control for this device is the FDA guidance document entitled “Class II Special Controls Guidance Document: Electrocardiograph Electrodes.” See § 870.1(e) for availability information of guidance documents.